Ipsen Biopharm Ltd in the United Kingdom is seeking an Early Development Asset Lead (EDAL) to drive scientific and program leadership for one or more early-stage assets. You will lead the Early Development Asset Team (EDT) spanning clinical, regulatory, CMC and translational activities, ensuring rigorous strategy and accountable portfolio decisions.
The EDAL will align with Therapeutic Area strategy, championing assigned programs, articulating goals and scientific rationale, and representing the
#J-18808-Ljbffr
Full job description from WhatJobs. Apply for this role →
London
Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical…
London
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease…
London
Titre : Early Development Asset Lead Société: Ipsen Biopharm Ltd A propos d'Ipsen: Ipsen est un groupe biopharmaceutique mondial de taille moyenne…
London
Ipsen Biopharm Ltd. is seeking an Early Development Asset Lead to drive integrated development strategy and execution for one or more early-stage…
London
In this role you lead one or more Early Development Asset Teams to shape the strategy and execution of early-stage therapeutic assets.
Wrexham, Clwyd
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease…
Explore: Specialist jobs in London
Worked with Verifera as a candidate or employer? Your honest review helps the next person trust verified hiring.